Global Pulmonary Embolectomy System Supply, Demand and Key Producers, 2026-2032

June 2026 | 125 pages | ID: GB03AB2178CBEN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Pulmonary Embolectomy System market size is expected to reach $ 1895 million by 2032, rising at a market growth of 7.5% CAGR during the forecast period (2026-2032).

Pulmonary embolectomy systems are specialized medical devices designed for the minimally invasive removal of thromboemboli from the pulmonary arteries to restore hemodynamic stability in patients with acute pulmonary embolism. These systems typically comprise aspiration catheters, mechanical thrombectomy devices, guidewires, and negative pressure aspiration pumps. Unlike traditional surgical embolectomy, catheter-based techniques achieve thrombus removal through percutaneous access, offering reduced procedural trauma, shorter hospital stays, and improved clinical outcomes for intermediate- and high-risk patients. Key technologies include large-bore aspiration catheters, mechanical fragmentation devices, and rheolytic thrombectomy systems. From a value chain perspective, upstream includes catheter material suppliers (medical-grade polymers, braiding wires), guidewire component manufacturers, aspiration pump and console producers, and packaging/sterilization service providers; midstream involves device assembly, quality control, regulatory certification (FDA, CE, NMPA), and distribution; downstream demand spans interventional cardiology departments, vascular surgery departments, interventional radiology departments, and intensive care units in hospitals. In 2025, the average selling price is approximately US$9,800 per unit, global sales volume is about 113.3k units, and gross margins generally range from 50% to 70%, driven by catheter material costs, device design complexity, regulatory approval barriers, and physician training requirements.

The pulmonary embolectomy system market is experiencing robust growth driven by the increasing global incidence of pulmonary embolism and the paradigm shift toward minimally invasive catheter-based interventions over traditional surgical embolectomy. According to the CDC, approximately 900,000 people in the United States are affected by deep vein thrombosis and pulmonary embolism annually, with about 60,000-100,000 deaths. This high disease burden, coupled with the availability of effective mechanical thrombectomy devices, has created substantial demand for pulmonary embolectomy systems.

Another key trend is the expansion of treatment guidelines that now recommend catheter-directed therapies for intermediate-risk pulmonary embolism patients. Previously, systemic anticoagulation was the standard of care for non-massive PE, but growing evidence supports the use of mechanical thrombectomy to reduce right ventricular strain, improve long-term functional outcomes, and prevent chronic thromboembolic pulmonary hypertension. This guideline expansion has significantly broadened the addressable patient population for pulmonary embolectomy systems.

The market is also witnessing significant technological innovation in next-generation thrombectomy devices. Key trends include the development of dual-action devices combining aspiration and mechanical fragmentation, enhanced navigability through complex pulmonary arterial anatomy, and real-time pressure monitoring for safer aspiration. These innovations are improving procedural efficienc

This report studies the global Pulmonary Embolectomy System production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Pulmonary Embolectomy System and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pulmonary Embolectomy System that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Pulmonary Embolectomy System total production and demand, 2021-2032, (K Units)
Global Pulmonary Embolectomy System total production value, 2021-2032, (USD Million)
Global Pulmonary Embolectomy System production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Pulmonary Embolectomy System consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Pulmonary Embolectomy System domestic production, consumption, key domestic manufacturers and share
Global Pulmonary Embolectomy System production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Pulmonary Embolectomy System production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Pulmonary Embolectomy System production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)

This report profiles key players in the global Pulmonary Embolectomy System market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Inari Medical, Inc., Penumbra, Inc., Boston Scientific Corporation, Medtronic plc, Teleflex Incorporated, Johnson & Johnson (Ethicon), Terumo Corporation, Kaneka Corporation, MicroPort Scientific Corporation, Lepu Medical Technology Co., Ltd., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pulmonary Embolectomy System market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global Pulmonary Embolectomy System Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global Pulmonary Embolectomy System Market, Segmentation by Type:
  • Large-Bore Aspiration Catheter (> 12F)
  • Medium-Bore Aspiration Catheter (8-12F)
  • Small-Bore Aspiration Catheter (< 8F)
Global Pulmonary Embolectomy System Market, Segmentation by Price Tier:
  • Standard (< US$7,000)
  • Premium (US$7,000-15,000)
  • Integrated System (> US$15,000)
Global Pulmonary Embolectomy System Market, Segmentation by Patient Risk Stratification:
  • High-Risk PE (Massive)
  • Intermediate-Risk PE (Submassive)
  • Low-Risk PE
Global Pulmonary Embolectomy System Market, Segmentation by Application:
  • Tertiary / Academic Medical Center
  • Regional / Community Hospital
  • Specialized Cardiovascular Center
Companies Profiled:
  • Inari Medical, Inc.
  • Penumbra, Inc.
  • Boston Scientific Corporation
  • Medtronic plc
  • Teleflex Incorporated
  • Johnson & Johnson (Ethicon)
  • Terumo Corporation
  • Kaneka Corporation
  • MicroPort Scientific Corporation
  • Lepu Medical Technology Co., Ltd.
  • Avinger, Inc.
  • Argon Medical Devices
  • Control Medical Technology
Key Questions Answered:
1. How big is the global Pulmonary Embolectomy System market?
2. What is the demand of the global Pulmonary Embolectomy System market?
3. What is the year over year growth of the global Pulmonary Embolectomy System market?
4. What is the production and production value of the global Pulmonary Embolectomy System market?
5. Who are the key producers in the global Pulmonary Embolectomy System market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 Pulmonary Embolectomy System Introduction
1.2 World Pulmonary Embolectomy System Supply & Forecast
1.2.1 World Pulmonary Embolectomy System Production Value (2021 & 2025 & 2032)
1.2.2 World Pulmonary Embolectomy System Production (2021-2032)
1.2.3 World Pulmonary Embolectomy System Pricing Trends (2021-2032)
1.3 World Pulmonary Embolectomy System Production by Region (Based on Production Site)
1.3.1 World Pulmonary Embolectomy System Production Value by Region (2021-2032)
1.3.2 World Pulmonary Embolectomy System Production by Region (2021-2032)
1.3.3 World Pulmonary Embolectomy System Average Price by Region (2021-2032)
1.3.4 North America Pulmonary Embolectomy System Production (2021-2032)
1.3.5 Europe Pulmonary Embolectomy System Production (2021-2032)
1.3.6 China Pulmonary Embolectomy System Production (2021-2032)
1.3.7 Japan Pulmonary Embolectomy System Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pulmonary Embolectomy System Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pulmonary Embolectomy System Major Market Trends

2 DEMAND SUMMARY

2.1 World Pulmonary Embolectomy System Demand (2021-2032)
2.2 World Pulmonary Embolectomy System Consumption by Region
2.2.1 World Pulmonary Embolectomy System Consumption by Region (2021-2026)
2.2.2 World Pulmonary Embolectomy System Consumption Forecast by Region (2027-2032)
2.3 United States Pulmonary Embolectomy System Consumption (2021-2032)
2.4 China Pulmonary Embolectomy System Consumption (2021-2032)
2.5 Europe Pulmonary Embolectomy System Consumption (2021-2032)
2.6 Japan Pulmonary Embolectomy System Consumption (2021-2032)
2.7 South Korea Pulmonary Embolectomy System Consumption (2021-2032)
2.8 ASEAN Pulmonary Embolectomy System Consumption (2021-2032)
2.9 India Pulmonary Embolectomy System Consumption (2021-2032)

3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World Pulmonary Embolectomy System Production Value by Manufacturer (2021-2026)
3.2 World Pulmonary Embolectomy System Production by Manufacturer (2021-2026)
3.3 World Pulmonary Embolectomy System Average Price by Manufacturer (2021-2026)
3.4 Pulmonary Embolectomy System Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Pulmonary Embolectomy System Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Pulmonary Embolectomy System in 2025
3.5.3 Global Concentration Ratios (CR8) for Pulmonary Embolectomy System in 2025
3.6 Pulmonary Embolectomy System Market: Overall Company Footprint Analysis
3.6.1 Pulmonary Embolectomy System Market: Region Footprint
3.6.2 Pulmonary Embolectomy System Market: Company Product Type Footprint
3.6.3 Pulmonary Embolectomy System Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: Pulmonary Embolectomy System Production Value Comparison
4.1.1 United States VS China: Pulmonary Embolectomy System Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Pulmonary Embolectomy System Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Pulmonary Embolectomy System Production Comparison
4.2.1 United States VS China: Pulmonary Embolectomy System Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Pulmonary Embolectomy System Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Pulmonary Embolectomy System Consumption Comparison
4.3.1 United States VS China: Pulmonary Embolectomy System Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Pulmonary Embolectomy System Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Pulmonary Embolectomy System Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Pulmonary Embolectomy System Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Pulmonary Embolectomy System Production Value (2021-2026)
4.4.3 United States Based Manufacturers Pulmonary Embolectomy System Production (2021-2026)
4.5 China Based Pulmonary Embolectomy System Manufacturers and Market Share
4.5.1 China Based Pulmonary Embolectomy System Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Pulmonary Embolectomy System Production Value (2021-2026)
4.5.3 China Based Manufacturers Pulmonary Embolectomy System Production (2021-2026)
4.6 Rest of World Based Pulmonary Embolectomy System Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Pulmonary Embolectomy System Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Pulmonary Embolectomy System Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Pulmonary Embolectomy System Production (2021-2026)

5 MARKET ANALYSIS BY TYPE

5.1 World Pulmonary Embolectomy System Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Large-Bore Aspiration Catheter (> 12F)
5.2.2 Medium-Bore Aspiration Catheter (8-12F)
5.2.3 Small-Bore Aspiration Catheter (< 8F)
5.3 Market Segment by Type
5.3.1 World Pulmonary Embolectomy System Production by Type (2021-2032)
5.3.2 World Pulmonary Embolectomy System Production Value by Type (2021-2032)
5.3.3 World Pulmonary Embolectomy System Average Price by Type (2021-2032)

6 MARKET ANALYSIS BY PRICE TIER

6.1 World Pulmonary Embolectomy System Market Size Overview by Price Tier: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Price Tier
6.2.1 Standard (< US$7,000)
6.2.2 Premium (US$7,000-15,000)
6.2.3 Integrated System (> US$15,000)
6.3 Market Segment by Price Tier
6.3.1 World Pulmonary Embolectomy System Production by Price Tier (2021-2032)
6.3.2 World Pulmonary Embolectomy System Production Value by Price Tier (2021-2032)
6.3.3 World Pulmonary Embolectomy System Average Price by Price Tier (2021-2032)

7 MARKET ANALYSIS BY PATIENT RISK STRATIFICATION

7.1 World Pulmonary Embolectomy System Market Size Overview by Patient Risk Stratification: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Patient Risk Stratification
7.2.1 High-Risk PE (Massive)
7.2.2 Intermediate-Risk PE (Submassive)
7.2.3 Low-Risk PE
7.3 Market Segment by Patient Risk Stratification
7.3.1 World Pulmonary Embolectomy System Production by Patient Risk Stratification (2021-2032)
7.3.2 World Pulmonary Embolectomy System Production Value by Patient Risk Stratification (2021-2032)
7.3.3 World Pulmonary Embolectomy System Average Price by Patient Risk Stratification (2021-2032)

8 MARKET ANALYSIS BY APPLICATION

8.1 World Pulmonary Embolectomy System Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Tertiary / Academic Medical Center
8.2.2 Regional / Community Hospital
8.2.3 Specialized Cardiovascular Center
8.3 Market Segment by Application
8.3.1 World Pulmonary Embolectomy System Production by Application (2021-2032)
8.3.2 World Pulmonary Embolectomy System Production Value by Application (2021-2032)
8.3.3 World Pulmonary Embolectomy System Average Price by Application (2021-2032)

9 COMPANY PROFILES

9.1 Inari Medical, Inc.
9.1.1 Inari Medical, Inc. Details
9.1.2 Inari Medical, Inc. Major Business
9.1.3 Inari Medical, Inc. Pulmonary Embolectomy System Product and Services
9.1.4 Inari Medical, Inc. Pulmonary Embolectomy System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Inari Medical, Inc. Recent Developments/Updates
9.1.6 Inari Medical, Inc. Competitive Strengths & Weaknesses
9.2 Penumbra, Inc.
9.2.1 Penumbra, Inc. Details
9.2.2 Penumbra, Inc. Major Business
9.2.3 Penumbra, Inc. Pulmonary Embolectomy System Product and Services
9.2.4 Penumbra, Inc. Pulmonary Embolectomy System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Penumbra, Inc. Recent Developments/Updates
9.2.6 Penumbra, Inc. Competitive Strengths & Weaknesses
9.3 Boston Scientific Corporation
9.3.1 Boston Scientific Corporation Details
9.3.2 Boston Scientific Corporation Major Business
9.3.3 Boston Scientific Corporation Pulmonary Embolectomy System Product and Services
9.3.4 Boston Scientific Corporation Pulmonary Embolectomy System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Boston Scientific Corporation Recent Developments/Updates
9.3.6 Boston Scientific Corporation Competitive Strengths & Weaknesses
9.4 Medtronic plc
9.4.1 Medtronic plc Details
9.4.2 Medtronic plc Major Business
9.4.3 Medtronic plc Pulmonary Embolectomy System Product and Services
9.4.4 Medtronic plc Pulmonary Embolectomy System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Medtronic plc Recent Developments/Updates
9.4.6 Medtronic plc Competitive Strengths & Weaknesses
9.5 Teleflex Incorporated
9.5.1 Teleflex Incorporated Details
9.5.2 Teleflex Incorporated Major Business
9.5.3 Teleflex Incorporated Pulmonary Embolectomy System Product and Services
9.5.4 Teleflex Incorporated Pulmonary Embolectomy System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Teleflex Incorporated Recent Developments/Updates
9.5.6 Teleflex Incorporated Competitive Strengths & Weaknesses
9.6 Johnson & Johnson (Ethicon)
9.6.1 Johnson & Johnson (Ethicon) Details
9.6.2 Johnson & Johnson (Ethicon) Major Business
9.6.3 Johnson & Johnson (Ethicon) Pulmonary Embolectomy System Product and Services
9.6.4 Johnson & Johnson (Ethicon) Pulmonary Embolectomy System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Johnson & Johnson (Ethicon) Recent Developments/Updates
9.6.6 Johnson & Johnson (Ethicon) Competitive Strengths & Weaknesses
9.7 Terumo Corporation
9.7.1 Terumo Corporation Details
9.7.2 Terumo Corporation Major Business
9.7.3 Terumo Corporation Pulmonary Embolectomy System Product and Services
9.7.4 Terumo Corporation Pulmonary Embolectomy System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Terumo Corporation Recent Developments/Updates
9.7.6 Terumo Corporation Competitive Strengths & Weaknesses
9.8 Kaneka Corporation
9.8.1 Kaneka Corporation Details
9.8.2 Kaneka Corporation Major Business
9.8.3 Kaneka Corporation Pulmonary Embolectomy System Product and Services
9.8.4 Kaneka Corporation Pulmonary Embolectomy System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Kaneka Corporation Recent Developments/Updates
9.8.6 Kaneka Corporation Competitive Strengths & Weaknesses
9.9 MicroPort Scientific Corporation
9.9.1 MicroPort Scientific Corporation Details
9.9.2 MicroPort Scientific Corporation Major Business
9.9.3 MicroPort Scientific Corporation Pulmonary Embolectomy System Product and Services
9.9.4 MicroPort Scientific Corporation Pulmonary Embolectomy System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 MicroPort Scientific Corporation Recent Developments/Updates
9.9.6 MicroPort Scientific Corporation Competitive Strengths & Weaknesses
9.10 Lepu Medical Technology Co., Ltd.
9.10.1 Lepu Medical Technology Co., Ltd. Details
9.10.2 Lepu Medical Technology Co., Ltd. Major Business
9.10.3 Lepu Medical Technology Co., Ltd. Pulmonary Embolectomy System Product and Services
9.10.4 Lepu Medical Technology Co., Ltd. Pulmonary Embolectomy System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Lepu Medical Technology Co., Ltd. Recent Developments/Updates
9.10.6 Lepu Medical Technology Co., Ltd. Competitive Strengths & Weaknesses
9.11 Avinger, Inc.
9.11.1 Avinger, Inc. Details
9.11.2 Avinger, Inc. Major Business
9.11.3 Avinger, Inc. Pulmonary Embolectomy System Product and Services
9.11.4 Avinger, Inc. Pulmonary Embolectomy System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Avinger, Inc. Recent Developments/Updates
9.11.6 Avinger, Inc. Competitive Strengths & Weaknesses
9.12 Argon Medical Devices
9.12.1 Argon Medical Devices Details
9.12.2 Argon Medical Devices Major Business
9.12.3 Argon Medical Devices Pulmonary Embolectomy System Product and Services
9.12.4 Argon Medical Devices Pulmonary Embolectomy System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Argon Medical Devices Recent Developments/Updates
9.12.6 Argon Medical Devices Competitive Strengths & Weaknesses
9.13 Control Medical Technology
9.13.1 Control Medical Technology Details
9.13.2 Control Medical Technology Major Business
9.13.3 Control Medical Technology Pulmonary Embolectomy System Product and Services
9.13.4 Control Medical Technology Pulmonary Embolectomy System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Control Medical Technology Recent Developments/Updates
9.13.6 Control Medical Technology Competitive Strengths & Weaknesses

10 INDUSTRY CHAIN ANALYSIS

10.1 Pulmonary Embolectomy System Industry Chain
10.2 Pulmonary Embolectomy System Upstream Analysis
10.2.1 Pulmonary Embolectomy System Core Raw Materials
10.2.2 Main Manufacturers of Pulmonary Embolectomy System Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Pulmonary Embolectomy System Production Mode
10.6 Pulmonary Embolectomy System Procurement Model
10.7 Pulmonary Embolectomy System Industry Sales Model and Sales Channels
10.7.1 Pulmonary Embolectomy System Sales Model
10.7.2 Pulmonary Embolectomy System Typical Distributors

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer


LIST OF TABLES

Table 1. World Pulmonary Embolectomy System Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Pulmonary Embolectomy System Production Value by Region (2021-2026) & (USD Million)
Table 3. World Pulmonary Embolectomy System Production Value by Region (2027-2032) & (USD Million)
Table 4. World Pulmonary Embolectomy System Production Value Market Share by Region (2021-2026)
Table 5. World Pulmonary Embolectomy System Production Value Market Share by Region (2027-2032)
Table 6. World Pulmonary Embolectomy System Production by Region (2021-2026) & (K Units)
Table 7. World Pulmonary Embolectomy System Production by Region (2027-2032) & (K Units)
Table 8. World Pulmonary Embolectomy System Production Market Share by Region (2021-2026)
Table 9. World Pulmonary Embolectomy System Production Market Share by Region (2027-2032)
Table 10. World Pulmonary Embolectomy System Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Pulmonary Embolectomy System Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Pulmonary Embolectomy System Major Market Trends
Table 13. World Pulmonary Embolectomy System Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Pulmonary Embolectomy System Consumption by Region (2021-2026) & (K Units)
Table 15. World Pulmonary Embolectomy System Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Pulmonary Embolectomy System Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Pulmonary Embolectomy System Producers in 2025
Table 18. World Pulmonary Embolectomy System Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Pulmonary Embolectomy System Producers in 2025
Table 20. World Pulmonary Embolectomy System Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Pulmonary Embolectomy System Company Evaluation Quadrant
Table 22. World Pulmonary Embolectomy System Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Pulmonary Embolectomy System Production Site of Key Manufacturer
Table 24. Pulmonary Embolectomy System Market: Company Product Type Footprint
Table 25. Pulmonary Embolectomy System Market: Company Product Application Footprint
Table 26. Pulmonary Embolectomy System Competitive Factors
Table 27. Pulmonary Embolectomy System New Entrant and Capacity Expansion Plans
Table 28. Pulmonary Embolectomy System Mergers & Acquisitions Activity
Table 29. United States VS China Pulmonary Embolectomy System Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Pulmonary Embolectomy System Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Pulmonary Embolectomy System Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Pulmonary Embolectomy System Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Pulmonary Embolectomy System Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Pulmonary Embolectomy System Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Pulmonary Embolectomy System Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Pulmonary Embolectomy System Production Market Share (2021-2026)
Table 37. China Based Pulmonary Embolectomy System Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Pulmonary Embolectomy System Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Pulmonary Embolectomy System Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Pulmonary Embolectomy System Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Pulmonary Embolectomy System Production Market Share (2021-2026)
Table 42. Rest of World Based Pulmonary Embolectomy System Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Pulmonary Embolectomy System Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Pulmonary Embolectomy System Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Pulmonary Embolectomy System Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Pulmonary Embolectomy System Production Market Share (2021-2026)
Table 47. World Pulmonary Embolectomy System Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Pulmonary Embolectomy System Production by Type (2021-2026) & (K Units)
Table 49. World Pulmonary Embolectomy System Production by Type (2027-2032) & (K Units)
Table 50. World Pulmonary Embolectomy System Production Value by Type (2021-2026) & (USD Million)
Table 51. World Pulmonary Embolectomy System Production Value by Type (2027-2032) & (USD Million)
Table 52. World Pulmonary Embolectomy System Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Pulmonary Embolectomy System Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Pulmonary Embolectomy System Production Value by Price Tier, (USD Million), 2021 & 2025 & 2032
Table 55. World Pulmonary Embolectomy System Production by Price Tier (2021-2026) & (K Units)
Table 56. World Pulmonary Embolectomy System Production by Price Tier (2027-2032) & (K Units)
Table 57. World Pulmonary Embolectomy System Production Value by Price Tier (2021-2026) & (USD Million)
Table 58. World Pulmonary Embolectomy System Production Value by Price Tier (2027-2032) & (USD Million)
Table 59. World Pulmonary Embolectomy System Average Price by Price Tier (2021-2026) & (US$/Unit)
Table 60. World Pulmonary Embolectomy System Average Price by Price Tier (2027-2032) & (US$/Unit)
Table 61. World Pulmonary Embolectomy System Production Value by Patient Risk Stratification, (USD Million), 2021 & 2025 & 2032
Table 62. World Pulmonary Embolectomy System Production by Patient Risk Stratification (2021-2026) & (K Units)
Table 63. World Pulmonary Embolectomy System Production by Patient Risk Stratification (2027-2032) & (K Units)
Table 64. World Pulmonary Embolectomy System Production Value by Patient Risk Stratification (2021-2026) & (USD Million)
Table 65. World Pulmonary Embolectomy System Production Value by Patient Risk Stratification (2027-2032) & (USD Million)
Table 66. World Pulmonary Embolectomy System Average Price by Patient Risk Stratification (2021-2026) & (US$/Unit)
Table 67. World Pulmonary Embolectomy System Average Price by Patient Risk Stratification (2027-2032) & (US$/Unit)
Table 68. World Pulmonary Embolectomy System Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Pulmonary Embolectomy System Production by Application (2021-2026) & (K Units)
Table 70. World Pulmonary Embolectomy System Production by Application (2027-2032) & (K Units)
Table 71. World Pulmonary Embolectomy System Production Value by Application (2021-2026) & (USD Million)
Table 72. World Pulmonary Embolectomy System Production Value by Application (2027-2032) & (USD Million)
Table 73. World Pulmonary Embolectomy System Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Pulmonary Embolectomy System Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Inari Medical, Inc. Basic Information, Manufacturing Base and Competitors
Table 76. Inari Medical, Inc. Major Business
Table 77. Inari Medical, Inc. Pulmonary Embolectomy System Product and Services
Table 78. Inari Medical, Inc. Pulmonary Embolectomy System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Inari Medical, Inc. Recent Developments/Updates
Table 80. Inari Medical, Inc. Competitive Strengths & Weaknesses
Table 81. Penumbra, Inc. Basic Information, Manufacturing Base and Competitors
Table 82. Penumbra, Inc. Major Business
Table 83. Penumbra, Inc. Pulmonary Embolectomy System Product and Services
Table 84. Penumbra, Inc. Pulmonary Embolectomy System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Penumbra, Inc. Recent Developments/Updates
Table 86. Penumbra, Inc. Competitive Strengths & Weaknesses
Table 87. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 88. Boston Scientific Corporation Major Business
Table 89. Boston Scientific Corporation Pulmonary Embolectomy System Product and Services
Table 90. Boston Scientific Corporation Pulmonary Embolectomy System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Boston Scientific Corporation Recent Developments/Updates
Table 92. Boston Scientific Corporation Competitive Strengths & Weaknesses
Table 93. Medtronic plc Basic Information, Manufacturing Base and Competitors
Table 94. Medtronic plc Major Business
Table 95. Medtronic plc Pulmonary Embolectomy System Product and Services
Table 96. Medtronic plc Pulmonary Embolectomy System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Medtronic plc Recent Developments/Updates
Table 98. Medtronic plc Competitive Strengths & Weaknesses
Table 99. Teleflex Incorporated Basic Information, Manufacturing Base and Competitors
Table 100. Teleflex Incorporated Major Business
Table 101. Teleflex Incorporated Pulmonary Embolectomy System Product and Services
Table 102. Teleflex Incorporated Pulmonary Embolectomy System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Teleflex Incorporated Recent Developments/Updates
Table 104. Teleflex Incorporated Competitive Strengths & Weaknesses
Table 105. Johnson & Johnson (Ethicon) Basic Information, Manufacturing Base and Competitors
Table 106. Johnson & Johnson (Ethicon) Major Business
Table 107. Johnson & Johnson (Ethicon) Pulmonary Embolectomy System Product and Services
Table 108. Johnson & Johnson (Ethicon) Pulmonary Embolectomy System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Johnson & Johnson (Ethicon) Recent Developments/Updates
Table 110. Johnson & Johnson (Ethicon) Competitive Strengths & Weaknesses
Table 111. Terumo Corporation Basic Information, Manufacturing Base and Competitors
Table 112. Terumo Corporation Major Business
Table 113. Terumo Corporation Pulmonary Embolectomy System Product and Services
Table 114. Terumo Corporation Pulmonary Embolectomy System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Terumo Corporation Recent Developments/Updates
Table 116. Terumo Corporation Competitive Strengths & Weaknesses
Table 117. Kaneka Corporation Basic Information, Manufacturing Base and Competitors
Table 118. Kaneka Corporation Major Business
Table 119. Kaneka Corporation Pulmonary Embolectomy System Product and Services
Table 120. Kaneka Corporation Pulmonary Embolectomy System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Kaneka Corporation Recent Developments/Updates
Table 122. Kaneka Corporation Competitive Strengths & Weaknesses
Table 123. MicroPort Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 124. MicroPort Scientific Corporation Major Business
Table 125. MicroPort Scientific Corporation Pulmonary Embolectomy System Product and Services
Table 126. MicroPort Scientific Corporation Pulmonary Embolectomy System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. MicroPort Scientific Corporation Recent Developments/Updates
Table 128. MicroPort Scientific Corporation Competitive Strengths & Weaknesses
Table 129. Lepu Medical Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 130. Lepu Medical Technology Co., Ltd. Major Business
Table 131. Lepu Medical Technology Co., Ltd. Pulmonary Embolectomy System Product and Services
Table 132. Lepu Medical Technology Co., Ltd. Pulmonary Embolectomy System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Lepu Medical Technology Co., Ltd. Recent Developments/Updates
Table 134. Lepu Medical Technology Co., Ltd. Competitive Strengths & Weaknesses
Table 135. Avinger, Inc. Basic Information, Manufacturing Base and Competitors
Table 136. Avinger, Inc. Major Business
Table 137. Avinger, Inc. Pulmonary Embolectomy System Product and Services
Table 138. Avinger, Inc. Pulmonary Embolectomy System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Avinger, Inc. Recent Developments/Updates
Table 140. Avinger, Inc. Competitive Strengths & Weaknesses
Table 141. Argon Medical Devices Basic Information, Manufacturing Base and Competitors
Table 142. Argon Medical Devices Major Business
Table 143. Argon Medical Devices Pulmonary Embolectomy System Product and Services
Table 144. Argon Medical Devices Pulmonary Embolectomy System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Argon Medical Devices Recent Developments/Updates
Table 146. Argon Medical Devices Competitive Strengths & Weaknesses
Table 147. Control Medical Technology Basic Information, Manufacturing Base and Competitors
Table 148. Control Medical Technology Major Business
Table 149. Control Medical Technology Pulmonary Embolectomy System Product and Services
Table 150. Control Medical Technology Pulmonary Embolectomy System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Control Medical Technology Recent Developments/Updates
Table 152. Control Medical Technology Competitive Strengths & Weaknesses
Table 153. Global Key Players of Pulmonary Embolectomy System Upstream (Raw Materials)
Table 154. Global Pulmonary Embolectomy System Typical Customers
Table 155. Pulmonary Embolectomy System Typical Distributors

LIST OF FIGURES

Figure 1. Pulmonary Embolectomy System Picture
Figure 2. World Pulmonary Embolectomy System Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Pulmonary Embolectomy System Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Pulmonary Embolectomy System Production (2021-2032) & (K Units)
Figure 5. World Pulmonary Embolectomy System Average Price (2021-2032) & (US$/Unit)
Figure 6. World Pulmonary Embolectomy System Production Value Market Share by Region (2021-2032)
Figure 7. World Pulmonary Embolectomy System Production Market Share by Region (2021-2032)
Figure 8. North America Pulmonary Embolectomy System Production (2021-2032) & (K Units)
Figure 9. Europe Pulmonary Embolectomy System Production (2021-2032) & (K Units)
Figure 10. China Pulmonary Embolectomy System Production (2021-2032) & (K Units)
Figure 11. Japan Pulmonary Embolectomy System Production (2021-2032) & (K Units)
Figure 12. Pulmonary Embolectomy System Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Pulmonary Embolectomy System Consumption (2021-2032) & (K Units)
Figure 15. World Pulmonary Embolectomy System Consumption Market Share by Region (2021-2032)
Figure 16. United States Pulmonary Embolectomy System Consumption (2021-2032) & (K Units)
Figure 17. China Pulmonary Embolectomy System Consumption (2021-2032) & (K Units)
Figure 18. Europe Pulmonary Embolectomy System Consumption (2021-2032) & (K Units)
Figure 19. Japan Pulmonary Embolectomy System Consumption (2021-2032) & (K Units)
Figure 20. South Korea Pulmonary Embolectomy System Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Pulmonary Embolectomy System Consumption (2021-2032) & (K Units)
Figure 22. India Pulmonary Embolectomy System Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Pulmonary Embolectomy System by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Pulmonary Embolectomy System Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Pulmonary Embolectomy System Markets in 2025
Figure 26. United States VS China: Pulmonary Embolectomy System Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Pulmonary Embolectomy System Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Pulmonary Embolectomy System Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Pulmonary Embolectomy System Production Market Share 2025
Figure 30. China Based Manufacturers Pulmonary Embolectomy System Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Pulmonary Embolectomy System Production Market Share 2025
Figure 32. World Pulmonary Embolectomy System Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Pulmonary Embolectomy System Production Value Market Share by Type in 2025
Figure 34. Large-Bore Aspiration Catheter (> 12F)
Figure 35. Medium-Bore Aspiration Catheter (8-12F)
Figure 36. Small-Bore Aspiration Catheter (< 8F)
Figure 37. World Pulmonary Embolectomy System Production Market Share by Type (2021-2032)
Figure 38. World Pulmonary Embolectomy System Production Value Market Share by Type (2021-2032)
Figure 39. World Pulmonary Embolectomy System Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Pulmonary Embolectomy System Production Value by Price Tier, (USD Million), 2021 & 2025 & 2032
Figure 41. World Pulmonary Embolectomy System Production Value Market Share by Price Tier in 2025
Figure 42. Standard (< US$7,000)
Figure 43. Premium (US$7,000-15,000)
Figure 44. Integrated System (> US$15,000)
Figure 45. World Pulmonary Embolectomy System Production Market Share by Price Tier (2021-2032)
Figure 46. World Pulmonary Embolectomy System Production Value Market Share by Price Tier (2021-2032)
Figure 47. World Pulmonary Embolectomy System Average Price by Price Tier (2021-2032) & (US$/Unit)
Figure 48. World Pulmonary Embolectomy System Production Value by Patient Risk Stratification, (USD Million), 2021 & 2025 & 2032
Figure 49. World Pulmonary Embolectomy System Production Value Market Share by Patient Risk Stratification in 2025
Figure 50. High-Risk PE (Massive)
Figure 51. Intermediate-Risk PE (Submassive)
Figure 52. Low-Risk PE
Figure 53. World Pulmonary Embolectomy System Production Market Share by Patient Risk Stratification (2021-2032)
Figure 54. World Pulmonary Embolectomy System Production Value Market Share by Patient Risk Stratification (2021-2032)
Figure 55. World Pulmonary Embolectomy System Average Price by Patient Risk Stratification (2021-2032) & (US$/Unit)
Figure 56. World Pulmonary Embolectomy System Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 57. World Pulmonary Embolectomy System Production Value Market Share by Application in 2025
Figure 58. Tertiary / Academic Medical Center
Figure 59. Regional / Community Hospital
Figure 60. Specialized Cardiovascular Center
Figure 61. World Pulmonary Embolectomy System Production Market Share by Application (2021-2032)
Figure 62. World Pulmonary Embolectomy System Production Value Market Share by Application (2021-2032)
Figure 63. World Pulmonary Embolectomy System Average Price by Application (2021-2032) & (US$/Unit)
Figure 64. Pulmonary Embolectomy System Industry Chain
Figure 65. Pulmonary Embolectomy System Procurement Model
Figure 66. Pulmonary Embolectomy System Sales Model
Figure 67. Pulmonary Embolectomy System Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source


More Publications